To clinically assess whether AR signaling impacts the PKA/SPP1 axis in PCa bone metastasis, we explored the Westbrooke et al. dataset [34] containing longitudinal samples of metastatic PCa before and after enzalutamide treatment. Here, SPP1 is linked to posterior cortical atrophy.